NOMAD POWER SOLUTIONS, INC. Proceeds from Contributed Capital
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Proceeds from Contributed Capital of $92.72 thousand for the 104-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2014-05-09
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for the quarter ending 2013-12-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for the quarter ending 2013-09-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for the quarter ending 2013-06-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for the quarter ending 2013-03-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for fiscal 2013 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for fiscal 2012 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for fiscal 2011 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from contributed capital for fiscal 2010 was $0.00.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month | Proceeds from Contributed Capital 71 month | Proceeds from Contributed Capital 74 month | Proceeds from Contributed Capital 77 month | Proceeds from Contributed Capital 80 month | Proceeds from Contributed Capital 83 month | Proceeds from Contributed Capital 86 month | Proceeds from Contributed Capital 89 month | Proceeds from Contributed Capital 92 month | Proceeds from Contributed Capital 95 month | Proceeds from Contributed Capital 98 month | Proceeds from Contributed Capital 101 month | Proceeds from Contributed Capital 104 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $92.72K 10-Q · filed 2014-05-09 | |||||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 10-K · filed 2014-03-21 | $92.72K 10-K · filed 2014-03-21 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 4 quarters · filed 2014-03-21 | $92.72K 10-Q · filed 2013-11-07 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 derived: sum of 4 quarters · filed 2014-03-21 | $92.72K 10-Q · filed 2013-08-05 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 derived: sum of 4 quarters · filed 2014-03-21 | $92.72K 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 10-K · filed 2014-03-21 | $92.72K 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 4 quarters · filed 2013-11-07 | $92.72K 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | $0.00 derived: sum of 3 quarters · filed 2013-08-05 | $0.00 derived: sum of 4 quarters · filed 2013-08-05 | $92.72K 10-Q · filed 2012-08-10 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | $92.72K 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $0.00 derived: sum of 3 quarters · filed 2013-03-15 | $0.00 10-K · filed 2013-03-15 | $92.72K 10-K · filed 2012-03-29 | |||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2012-11-13 | $92.72K 10-Q · filed 2011-11-10 | |||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $0.00 10-Q · filed 2012-08-10 | $0.00 derived: sum of 3 quarters · filed 2012-08-10 | $0.00 derived: sum of 4 quarters · filed 2012-08-10 | $92.72K 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-05-10 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | |||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $0.00 derived: sum of 2 quarters · filed 2012-03-29 | $0.00 10-K · filed 2012-03-29 | |||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $0.00 10-Q · filed 2011-11-10 | ||||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |